Related Experiment Videos
Reproductive studies in the iron-deficient rat
Teratology
|December 1, 1980
Summary
Severe iron deficiency anemia in pregnant rats led to high fetal mortality and smaller offspring. Early iron supplementation prevented losses and improved hemoglobin levels, highlighting iron
Area of Science:
- Reproductive biology
- Hematology
- Nutritional science
Background:
- Iron deficiency anemia is a global health concern.
- Anemia can impact reproductive outcomes.
- The effects of severe anemia on pregnancy in mammals require further investigation.
Purpose of the Study:
- To investigate the impact of severe iron deficiency anemia on pregnancy in a rat model.
- To determine the effects of maternal anemia on fetal development and viability.
- To assess the efficacy of iron supplementation in mitigating adverse pregnancy outcomes.
Main Methods:
- Induction of severe iron deficiency anemia in pregnant rats via diet.
- Control group received iron supplementation.
- Monitoring of pregnancy parameters including corpora lutea, implantation sites, resorptions, and fetal viability.
- Assessment of fetal and maternal hemoglobin levels and fetal growth.
- Evaluation of iron supplementation timing on pregnancy outcomes.
Main Results:
- Iron-deficient rats exhibited high rates of embryonic and fetal resorption, with only 25% viable fetuses at day 20.
- Peak fetal mortality occurred around day 12 of gestation.
- Viable fetuses from deficient mothers were smaller, with a female predominance and increased eye defects.
- Maternal and fetal hemoglobin levels were significantly reduced (averaging 4.5 and 4.7 gm/dl, respectively).
- Partial iron treatment on days 0 and 7, or day 7, prevented fetal loss and improved hemoglobin concentrations.
Conclusions:
- Severe iron deficiency anemia profoundly impairs pregnancy outcomes in rats, leading to high fetal mortality and developmental issues.
- Early iron supplementation is crucial for preventing pregnancy complications associated with anemia.
- Restoring iron levels can partially correct hematological parameters and improve fetal survival rates.